British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids
暂无分享,去创建一个
C. Gordon | I. Giles | K. Schreiber | L. Warburton | M. Dey | C. Yee | K. Hodson | S. Panchal | J. Flint | M. Russell | M. van de Venne | M. Gayed | L. Moore | Amy Crossley | M. Piper | David Williams | Philippa Davie | Alexander Allen | M. Khamashta | M. Frishman | K. Saxby | Naz Senvar | S. Tosounidou | Clare Reid | Katherine Saxby
[1] J. Saito,et al. Ustekinumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk, and infant serum , 2022, Journal of Pharmaceutical Health Care and Sciences.
[2] M. Dubinsky,et al. Pharmacovigilance pregnancy data in a large population of patients with chronic inflammatory disease exposed to certolizumab pegol , 2021, Therapeutic advances in musculoskeletal disease.
[3] R. Xu,et al. Birth Outcomes in Women Who Have Taken Hydroxycholoroquine During Pregnancy: A Prospective Cohort Study , 2021, Arthritis & rheumatology.
[4] T. Burki. FDA approval for anifrolumab in patients with lupus , 2021, The Lancet Rheumatology.
[5] Hanh Nguyen,et al. A Systematic Review of the safety of non-TNF inhibitor biologic and targeted synthetic drugs in rheumatic disease in pregnancy. , 2021, Seminars in arthritis and rheumatism.
[6] J. Girling,et al. Pre-pregnancy care and contraception – the two-sided coin of reproductive health and safe prescribing , 2021, Obstetric medicine.
[7] M. Taheri,et al. Effects of chemotherapeutic agents on male germ cells and possible ameliorating impact of antioxidants. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[8] J. Kao,et al. Pregnancy outcomes in patients treated with belimumab: Report from real-world experience. , 2021, Seminars in arthritis and rheumatism.
[9] M. Pieri,et al. Survival of Vaccine-Induced Human Milk SARS-CoV-2 IgG, IgA and SIgA Immunoglobulins across Simulated Human Infant Gastrointestinal Digestion , 2021, medRxiv.
[10] A. Tincani,et al. POS0702 PREGNANCY IN SLE PATIENTS TREATED WITH BELIMUMAB: EXPERIENCE FROM 3 ITALIAN CENTERS , 2021 .
[11] B. Goulden,et al. P202 Administering live vaccines to infants exposed to biologic and targeted synthetic DMARDs in-utero for maternal treatment of rheumatic disease: a systematic review of the literature , 2021, Rheumatology.
[12] C. Gordon,et al. Prescribing anti-rheumatic drugs in pregnancy and breastfeeding - the BSR guideline scope. , 2021, Rheumatology.
[13] R. Erra,et al. Low incidence of intrauterine growth restriction in pregnant patients with systemic lupus erythematosus taking hydroxychloroquine , 2021, Immunological medicine.
[14] A. Amiot,et al. Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study , 2020, Alimentary pharmacology & therapeutics.
[15] M. Sahraian,et al. Pregnancy outcome in patients with multiple sclerosis treated with Rituximab: A case-series study. , 2020, Multiple sclerosis and related disorders.
[16] M. Beksaç,et al. Impact of hydroxychloroquine on the gestational outcomes of pregnant women with immune system problems that necessitate the use of the drug , 2020, The journal of obstetrics and gynaecology research.
[17] D. Hervás,et al. Histologic Analysis of Testes from Prepubertal Patients Treated with Chemotherapy Associates Impaired Germ Cell Counts with Cumulative Doses of Cyclophosphamide, Ifosfamide, Cytarabine, and Asparaginase , 2020, Reproductive Sciences.
[18] A. Zainuddin,et al. New Benefits of Hydroxychloroquine in Pregnant Women with Systemic Lupus Erythematosus: A Retrospective Study in a Tertiary Centre , 2020, Revista Brasileira de Ginecologia e Obstetricia / RBGO - Gynecology and Obstetrics.
[19] J. Saito,et al. Tocilizumab drug levels during pregnancy and lactation: A woman who discontinued tocilizumab therapy until the end of the first trimester and resumed it after birth , 2020, Obstetric Medicine.
[20] P. C. T. ter Borg,et al. Health outcomes of 1000 children born to mothers with inflammatory bowel disease in their first 5 years of life , 2020, Gut.
[21] M. Dubinsky,et al. S0847 Pregnancy Outcomes in the Tofacitinib Ulcerative Colitis OCTAVE Studies: An Update as of February 2020 , 2020 .
[22] S. Hernández-Díaz,et al. Hydroxychloroquine early in pregnancy and risk of birth defects , 2020, American Journal of Obstetrics and Gynecology.
[23] Huixia Yang,et al. Effect of hydroxychloroquine on preeclampsia in lupus pregnancies: a propensity score-matched analysis and meta-analysis , 2020, Archives of Gynecology and Obstetrics.
[24] L. Pączek,et al. Low Content of Cyclosporine A and Its Metabolites in the Colostrum of Post-Transplant Mothers , 2020, Nutrients.
[25] R. Hasz,et al. PREGNANCY OUTCOMES IN 1164 FEMALE KIDNEY TRANSPLANT RECIPIENTS , 2020 .
[26] C. Boz,et al. Methylprednisolone Concentrations in Breast Milk and Serum of Patients with Multiple Sclerosis Treated with IV Pulse Methylprednisolone , 2020, Clinical Neurology and Neurosurgery.
[27] M. Gissler,et al. Paediatric infections in the first 3 years of life after maternal anti‐TNF treatment during pregnancy , 2020, Alimentary pharmacology & therapeutics.
[28] B. Nørgård,et al. In utero exposure to thiopurines/anti‐TNF agents and long‐term health outcomes during childhood and adolescence in Denmark , 2020, Alimentary pharmacology & therapeutics.
[29] M. Said,et al. Adverse pregnancy outcomes among multi-ethnic systemic lupus erythematosus patients in Malaysia , 2020, Lupus.
[30] Mimi Y. Kim,et al. Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers. , 2020, Journal of the American College of Cardiology.
[31] F. Pérez-Cano,et al. The Immature Gut Barrier and Its Importance in Establishing Immunity in Newborn Mammals , 2020, Frontiers in Immunology.
[32] R. Fischer-Betz,et al. AB0375 SAFETY AND BENEFICIAL EFFECTS OF HYDROXYCHLOROQUINE ON PREGNANCY OUTCOMES IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS , 2020, Annals of the Rheumatic Diseases.
[33] A. Geldhof,et al. SAT0117 TRIMESTER EXPOSURE AND PREGNANCY OUTCOMES IN WOMEN EXPOSED TO GOLIMUMAB – RESULTS FROM THE COMPANY PHARMACOVIGILANCE DATABASE , 2020 .
[34] P. Truffinet,et al. Pregnancy outcomes in patients treated with leflunomide, the parent compound of the multiple sclerosis drug teriflunomide. , 2020, Reproductive toxicology.
[35] D. Lyell,et al. Rituximab, MS, and pregnancy , 2020, Neurology: Neuroimmunology & Neuroinflammation.
[36] S. Rasmussen,et al. Risk of pregnancy loss in patients exposed to mycophenolate compared to azathioprine: A retrospective cohort study , 2020, Pharmacoepidemiology and drug safety.
[37] J. Saito,et al. Belimumab Concentrations in Maternal Serum and Breast Milk During Breastfeeding and the Safety Assessment of the Infant: A Case Study. , 2020, Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.
[38] M. Gissler,et al. Anti‐TNF treatment during pregnancy and birth outcomes: A population‐based study from Denmark, Finland, and Sweden , 2020, Pharmacoepidemiology and drug safety.
[39] A. Akdoğan,et al. Pregnancy outcomes in partners of male ankylosing spondylitis patients treated with anti-tumour necrosis factor-α biologics: real-life results from a single-centre cross-sectional study , 2020, Rheumatology International.
[40] S. D. Del Giacco,et al. Baricitinib exposure during pregnancy in rheumatoid arthritis , 2020, Therapeutic advances in musculoskeletal disease.
[41] C. B. Lin,et al. Pregnancy Outcomes in Women with Psoriasis, Psoriatic Arthritis, Crohn’s Disease, and Ulcerative Colitis Treated with Ustekinumab , 2020, Zeitschrift für Gastroenterologie.
[42] A. Subramaniam,et al. Systemic Lupus Erythematosus: Perinatal Outcomes in Patients Treated With and Without Hydroxychloroquine , 2020, The Ochsner journal.
[43] J. Efron,et al. Early Discontinuation of Infliximab in Pregnant Women With Inflammatory Bowel Disease. , 2020, Inflammatory bowel diseases.
[44] C. Chambers,et al. Pregnancy outcomes in patients with multiple sclerosis treated with teriflunomide: Clinical study data and 5 years of post-marketing experience , 2019, Multiple sclerosis.
[45] Y. Murakawa,et al. Unexpectedly lower proportion of placental transferred tocilizumab relative to whole immunoglobulin G: a case report , 2020, Scandinavian journal of rheumatology.
[46] S. Vermeire,et al. Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti‐TNF or conventional therapy: results of the European CONCEIVE study , 2020, Alimentary pharmacology & therapeutics.
[47] M. Meistrich. Risks of genetic damage in offspring conceived using spermatozoa produced during chemotherapy or radiotherapy , 2019, Andrology.
[48] Sara C. LaHue,et al. Minimal breast milk transfer of rituximab, a monoclonal antibody used in neurological conditions , 2019, Neurology: Neuroimmunology & Neuroinflammation.
[49] A. Geldhof,et al. Exposure to Infliximab During Pregnancy: Post-Marketing Experience , 2019, Drug Safety.
[50] R. Xu,et al. Birth outcomes in women who have taken adalimumab in pregnancy: A prospective cohort study , 2019, PloS one.
[51] R. Xu,et al. Oral corticosteroid use during pregnancy and risk of preterm birth. , 2019, Rheumatology.
[52] Long Zhao,et al. A randomized controlled trial of etanercept in the treatment of refractory recurrent spontaneous abortion with innate immune disorders. , 2019, Taiwanese journal of obstetrics & gynecology.
[53] K. Zagorodnikova,et al. #3 Pregancy and infant outcomes after maternal exposure to rituximab , 2019, Reproductive Toxicology.
[54] Y. Tada,et al. Placental transfer of tocilizumab in a patient with rheumatoid arthritis. , 2019, Rheumatology.
[55] J. Saito,et al. Abatacept concentrations in maternal serum and breast milk during breastfeeding and an infant safety assessment: a case study. , 2019, Rheumatology.
[56] K. Minden,et al. Pregnancy outcomes in DMARD-exposed patients with juvenile idiopathic arthritis-results from a JIA biologic registry. , 2019, Rheumatology.
[57] A. Åsberg,et al. Immunosuppression and reproductive health after kidney transplantation. , 2019, Transplantation.
[58] D. Mei,et al. Breast milk concentration of hydroxychloroquine in Chinese lactating women with connective tissue diseases , 2019, European Journal of Clinical Pharmacology.
[59] Saeed Hesam,et al. The effect of lupus disease on the pregnant women and embryos: a retrospective study from 2010 to 2014 , 2019, Clinical Rheumatology.
[60] Marcus John Beasley,et al. FRI0569 WHAT DOES IT MEAN TO BECOME PREGNANT WITH JUVENILE IDIOPATHIC ARTHRITIS? A MONOCENTRIC EXPERIENCE IN A TERTIARY CENTRE OF MILAN DEDICATED TO YOUNG ADULTS AFFECTED BY JIA , 2019, Paediatric rheumatology.
[61] H. Dobashi,et al. FRI0209 LOW-DOSE GLUCOCORTICOID COULD AFFECT ADVERSE PREGNANCY OUTCOMES, ESPECIALLY IN PRETERM BIRTH, LIGHT-FOR-DATE NEWBORNS, PRETERM PREMATURE RUPTURE OF MEMBRANE IN CONNECTIVE TISSUE DISEASE PATIENTS , 2019, Poster Presentations.
[62] C. Vermehren,et al. P06 Paternal exposure to methotrexate and the risk of miscarriage – a register based nationwide cohort study , 2019, Archives of Disease in Childhood.
[63] E. Soriano,et al. Causes of fetal third-degree atrioventricular block and use of hydroxychloroquine in pregnant women with Ro/La antibodies , 2019, Clinical Rheumatology.
[64] H. Cha,et al. Hydroxychloroquine treatment during pregnancy in lupus patients is associated with lower risk of preeclampsia , 2019, Lupus.
[65] J. Clark,et al. In utero exposure to biologic disease-modifying anti-rheumatic drugs and effects to the infant: infectious complications, vaccine response, and safety of live vaccine administration , 2019, Expert review of vaccines.
[66] M. Mouyis,et al. Safety of anti-rheumatic drugs in men trying to conceive: A systematic review and analysis of published evidence. , 2019, Seminars in arthritis and rheumatism.
[67] M. Dubinsky,et al. Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group. , 2019, Gastroenterology.
[68] T. Hale,et al. Cyclophosphamide Use in Multiple Sclerosis: Levels Detected in Human Milk. , 2019, Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.
[69] R. Ionescu,et al. Pregnancy Outcomes in Couples with Males Exposed to Longterm Anti–tumor Necrosis Factor–α Inhibitor Therapies: A Prospective Study , 2019, The Journal of Rheumatology.
[70] L. Lynd,et al. Use of biologics during pregnancy and risk of serious infections in the mother and baby: a Canadian population-based cohort study , 2019, BMJ Open.
[71] K. Top,et al. From mother to baby: antenatal exposure to monoclonal antibody biologics , 2019, Expert review of clinical immunology.
[72] M. Neurath,et al. Drug Levels in the Maternal Serum, Cord Blood and Breast Milk of a Ustekinumab-Treated Patient with Crohn's Disease. , 2018, Journal of Crohn's & colitis.
[73] N. Reynolds,et al. Ustekinumab exposure during conception and pregnancy in patients with chronic plaque psoriasis: a case series of 10 pregnancies , 2018, The British journal of dermatology.
[74] M. Lukáš,et al. Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation. , 2018, Inflammatory bowel diseases.
[75] J. Humphreys,et al. The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis-Executive summary. , 2018, Rheumatology.
[76] Steven J Brown,et al. Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes. , 2019, Inflammatory Bowel Diseases.
[77] Y. Nagayasu,et al. Changes in the blood level, efficacy, and safety of tacrolimus in pregnancy and the lactation period in patients with systemic lupus erythematosus , 2018, Lupus.
[78] S. Aoki,et al. Pregnancy Outcomes of Patients Exposed to Adalimumab in Japan , 2018, Digestive Diseases.
[79] G. E. Potter,et al. Chloroquine as weekly chemoprophylaxis or intermittent treatment to prevent malaria in pregnancy in Malawi: a randomised controlled trial. , 2018, The Lancet. Infectious diseases.
[80] P. Aljama,et al. Administration of mycophenolic acid is not associated with malformations in descendants from kidney transplanted males , 2018, PloS one.
[81] B. Strober,et al. Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database , 2018, The British journal of dermatology.
[82] Christopher F. Martin,et al. Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development. , 2018, Gastroenterology.
[83] S. Caritis,et al. Prednisone Pharmacokinetics During Pregnancy and Lactation , 2018, Journal of clinical pharmacology.
[84] M. Abrahamowicz,et al. Serious Infections in Rheumatoid Arthritis Offspring Exposed to Tumor Necrosis Factor Inhibitors , 2018, Arthritis & rheumatology.
[85] J. Ioannidis,et al. Corticosteroids for preventing neonatal respiratory morbidity after elective caesarean section at term. , 2018, The Cochrane database of systematic reviews.
[86] J. Saito,et al. Tocilizumab concentrations in maternal serum and breast milk during breastfeeding and a safety assessment in infants: a case study. , 2018, Rheumatology.
[87] D. Rizopoulos,et al. Anti-TNF Levels in Cord Blood at Birth are Associated with Anti-TNF Type , 2018, Journal of Crohn's & colitis.
[88] W. Sandborn,et al. Pregnancy Outcomes Reported During the 13‐Year TREAT Registry: A Descriptive Report , 2018, The American Journal of Gastroenterology.
[89] Xiao-hui Zhang,et al. Evaluation of glucocorticoid compared with immunoglobulin therapy of severe immune thrombocytopenia during pregnancy: Response rate and complication , 2018, American journal of reproductive immunology.
[90] S. Feldman,et al. Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis , 2018, Inflammatory bowel diseases.
[91] A. Barkun,et al. Continuous Anti‐TNF&agr; Use Throughout Pregnancy: Possible Complications For the Mother But Not for the Fetus. A Retrospective Cohort on the French National Health Insurance Database (EVASION) , 2018, The American Journal of Gastroenterology.
[92] T. Hale,et al. High-Dose Methotrexate Treatment in a Breastfeeding Mother with Placenta Accreta: A Case Report. , 2018, Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.
[93] C. Chambers,et al. Five successful pregnancies with antenatal anakinra exposure , 2018, Rheumatology.
[94] Springer Fachmedien Wiesbaden,et al. Service , 2018, Wirtschaftsinformatik Manag..
[95] C. Selmi,et al. THU0319 Overall safety of 7-week secukinumab exposure during pregnancy in women with psoriatic arthritis , 2018, THURSDAY, 14 JUNE 2018:.
[96] D. Dallas,et al. Comparison of Human Milk Immunoglobulin Survival during Gastric Digestion between Preterm and Term Infants , 2018, Nutrients.
[97] M. Moritz,et al. Pregnancy Outcomes in 91 Female Heart Transplant Recipients , 2018 .
[98] M. Østensen,et al. Lymphocyte changes and vaccination response in a child exposed to belimumab during pregnancy , 2018, Annals of the rheumatic diseases.
[99] L. Lynd,et al. Risk of preterm delivery and small-for-gestational-age births in women with autoimmune disease using biologics before or during pregnancy: a population-based cohort study , 2018, Annals of the rheumatic diseases.
[100] E. Grandone,et al. Effect of Additional Treatments Combined with Conventional Therapies in Pregnant Patients with High-Risk Antiphospholipid Syndrome: A Multicentre Study , 2018, Thrombosis and Haemostasis.
[101] L. Pączek,et al. Low Transfer of Tacrolimus and Its Metabolites into Colostrum of Graft Recipient Mothers , 2018, American Journal of Perinatology.
[102] J. Gisbert,et al. Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study , 2018, The American Journal of Gastroenterology.
[103] M. Lukáš,et al. P614 Pregnancy outcomes in women with IBD treated with biosimilar infliximab , 2018 .
[104] P. Villiger,et al. Paternal exposure to antirheumatic drugs-What physicians should know: Review of the literature. , 2018, Seminars in arthritis and rheumatism.
[105] B. Nørgård,et al. Birth Outcome of Children Fathered by Men Treated with Systemic Corticosteroids during the Conception Period – A Cohort Study based on Nationwide Data , 2018, Basic & clinical pharmacology & toxicology.
[106] S. Colilla,et al. Leflunomide use during pregnancy and the risk of adverse pregnancy outcomes , 2017, Annals of the rheumatic diseases.
[107] S. Lydersen,et al. Influence of disease activity and medications on offspring birth weight, pre-eclampsia and preterm birth in systemic lupus erythematosus: a population-based study , 2017, Annals of the rheumatic diseases.
[108] X. Mariette,et al. Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study , 2017, Annals of the rheumatic diseases.
[109] C. Vermehren,et al. Paternal exposure to methotrexate and the risk of miscarriage - a register based nationwide cohort study , 2018 .
[110] Enling Liu,et al. Feasibility of hydroxychloroquine adjuvant therapy in pregnant women with systemic lupus erythematosus , 2018 .
[111] D. Furst,et al. Long‐Term Safety of Rituximab in Patients With Rheumatoid Arthritis: Results of a Five‐Year Observational Study , 2019, Arthritis care & research.
[112] A. Kimball,et al. Length Pregnancy Outcomes after Exposure to Certolizumab Pegol : Updated Results from a Pharmacovigilance Safety Database , 2018 .
[113] I. Bruce,et al. The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults , 2018, Rheumatology.
[114] J. V. van Laar,et al. Hydroxychloroquine Use in Lupus Patients during Pregnancy Is Associated with Longer Pregnancy Duration in Preterm Births , 2017, Journal of immunology research.
[115] P. Hawkins,et al. International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors , 2017, Rheumatology.
[116] B. Nørgård,et al. Birth outcomes after preconception paternal exposure to methotrexate: A nationwide cohort study. , 2017, Reproductive toxicology.
[117] B. Nørgård,et al. Paternal use of azathioprine/6-mercaptopurine or methotrexate within 3 months before conception and long-term health outcomes in the offspring-A nationwide cohort study. , 2017, Reproductive toxicology.
[118] E. Jaeggi,et al. Prenatal exposure to antimalarials decreases the risk of cardiac but not non-cardiac neonatal lupus: a single-centre cohort study , 2017, Rheumatology.
[119] M. Anthony,et al. Pregnancy and infant outcomes including major congenital malformations among women with chronic inflammatory arthritis or psoriasis, with and without etanercept use , 2017, Pharmacoepidemiology and drug safety.
[120] J. Thorp,et al. Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study , 2017, Annals of the rheumatic diseases.
[121] G. Gislason,et al. Birth Outcomes in Children Fathered by Men Treated with Immunosuppressant Drugs before Conception-A Danish Population-Based Cohort Study. , 2017, The Journal of investigative dermatology.
[122] C. Weber-Schoendorfer,et al. Leflunomide - A human teratogen? A still not answered question. An evaluation of the German Embryotox pharmacovigilance database. , 2017, Reproductive toxicology.
[123] D. Symmons,et al. Pregnancy outcomes in women with rheumatoid arthritis ever treated with rituximab. , 2017, Rheumatology.
[124] H. Poulsen,et al. Risk of Adverse Pregnancy Outcome After Paternal Exposure to Methotrexate Within 90 Days Before Pregnancy. , 2017, Obstetrics and gynecology.
[125] A. Åsberg,et al. Exposure to Mycophenolate and Fatherhood , 2017, Transplantation.
[126] Julie Brown,et al. Antenatal Corticosteroids for Accelerating Fetal Lung Maturation for Women at Risk of Preterm Birth , 2007, The Cochrane database of systematic reviews.
[127] D. Baeten,et al. Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients , 2017, Arthritis Research & Therapy.
[128] S. Hernández-Díaz,et al. Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study , 2017, British Medical Journal.
[129] S. De Vita,et al. Pregnancy and foetal outcomes following anti-tumor necrosis factor alpha therapy: A prospective multicentre study. , 2017, Joint, bone, spine : revue du rhumatisme.
[130] R. Landewé,et al. Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis , 2016, Annals of the rheumatic diseases.
[131] R. Fischer-Betz,et al. EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome , 2015, Annals of the rheumatic diseases.
[132] M. Hoeltzenbein,et al. Tocilizumab use in pregnancy: Analysis of a global safety database including data from clinical trials and post-marketing data. , 2016, Seminars in arthritis and rheumatism.
[133] B. Nørgård,et al. Birth Outcomes in Children Fathered by Men Treated with Anti-TNF-α Agents Before Conception , 2016, The American Journal of Gastroenterology.
[134] P. Shah,et al. Corticosteroids compared with intravenous immunoglobulin for the treatment of immune thrombocytopenia in pregnancy. , 2016, Blood.
[135] D. Jayne,et al. SUMMARY OF PRODUCT CHARACTERISTICS , 2014 .
[136] B. Nørgård,et al. Reassuring results on birth outcomes in children fathered by men treated with azathioprine/6-mercaptopurine within 3 months before conception: a nationwide cohort study , 2016, Gut.
[137] Steven J Brown,et al. Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection. , 2016, Gastroenterology.
[138] J. Kimani,et al. Efficacy and Safety of Azithromycin-Chloroquine versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Plasmodium falciparum Malaria Infection in Pregnant Women in Africa: An Open-Label, Randomized Trial , 2016, PloS one.
[139] S. Feldman,et al. Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis , 2016, Drug Safety.
[140] F. Dall’ara,et al. FRI0176 Safety of anti-TNF Alfa Agents during Pregancy and Breastfeeding: Longterm Follow up of Exposed Children in A Case-Series of Mothers with Chronic Arthritides , 2016 .
[141] A. Tincani,et al. The Efficacy and Safety of Cyclosporin A in Pregnant Patients with Systemic Autoimmune Diseases , 2016, American Journal of Reproductive Immunology.
[142] P. Villiger,et al. Certolizumab treatment during late pregnancy in patients with rheumatic diseases: Low drug levels in cord blood but possible risk for maternal infections. A case series of 13 patients. , 2016, Joint, bone, spine : revue du rhumatisme.
[143] C. Weber-Schoendorfer,et al. Pregnancy outcome after tocilizumab therapy in early pregnancy-a case series from the German Embryotox Pharmacovigilance Center. , 2016, Reproductive toxicology.
[144] T. Matsui,et al. Pregnancy outcome in women with inflammatory bowel disease treated with anti-tumor necrosis factor and/or thiopurine therapy: a multicenter study from Japan , 2016, Intestinal research.
[145] M. Mochizuki,et al. Pregnancy outcomes after exposure to tocilizumab: A retrospective analysis of 61 patients in Japan , 2016, Modern rheumatology.
[146] R. Fischer-Betz,et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation , 2016, Annals of the rheumatic diseases.
[147] H. Sørensen,et al. Low Risk of Birth Defects for Infants Whose Mothers Are Treated With Anti-Tumor Necrosis Factor Agents During Pregnancy. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[148] S. Sciascia,et al. The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies. , 2016, American journal of obstetrics and gynecology.
[149] G. Koren,et al. Challenges in vaccinating infants born to mothers taking immunoglobulin biologicals during pregnancy , 2016, Expert review of vaccines.
[150] C. Gordon,et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. , 2016, Rheumatology.
[151] C. Gordon,et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part II: analgesics and other drugs used in rheumatology practice. , 2016, Rheumatology.
[152] Monica Kumar,et al. Pregnancy outcomes following exposure to abatacept during pregnancy. , 2015, Seminars in arthritis and rheumatism.
[153] D. Wolf,et al. Pregnancy Outcomes in Subjects Exposed to Certolizumab Pegol , 2015, The Journal of Rheumatology.
[154] S. Caritis,et al. Pharmacokinetics of drugs in pregnancy. , 2015, Seminars in perinatology.
[155] H. Ozdogan,et al. How safe it is to treat pregnant FMF patients with Anakinra? , 2015, Pediatric Rheumatology.
[156] N. Heaton,et al. Outcomes of pregnancy following liver transplantation: The King's College Hospital experience , 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[157] Yan Zhao,et al. Pregnancy outcome of 126 anti-SSA/Ro-positive patients during the past 24 years—a retrospective cohort study , 2015, Clinical Rheumatology.
[158] E. Baldissera,et al. Prospectively-followed pregnancies in patients with inflammatory arthritis taking biological drugs: an Italian multicentre study. , 2015, Clinical and experimental rheumatology.
[159] J. Laven,et al. Brief Report: Miscarriages in Female Rheumatoid Arthritis Patients: Associations With Serologic Findings, Disease Activity, and Antirheumatic Drug Treatment , 2015, Arthritis & rheumatology.
[160] E. Lazaro,et al. Impact of hydroxychloroquine on preterm delivery and intrauterine growth restriction in pregnant women with systemic lupus erythematosus: a descriptive cohort study , 2015, Lupus.
[161] L. Jara,et al. Azathioprine during pregnancy in systemic lupus erythematosus patients is not associated with poor fetal outcome , 2015, Clinical Rheumatology.
[162] B. Kısacık,et al. AB1121 Anti-TNF Drugs May Result to Elevated Abortion Rates in Late Pregnancy , 2015 .
[163] J. Listing,et al. OP0017 Pregnancies in Patients with Rheumatoid Arthritis: Treatment Decisions, Course of the Disease, and Pregnancy Outcomes , 2015 .
[164] A. Tincani,et al. SAT0159 Long-Term Follow-Up of Children Born to Mothers with Chronic Arthritides and Exposed in Utero to Anti-TNF-Alpha Agents: A Case-Control Study , 2015 .
[165] F. Maurier,et al. The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective study. , 2015, Autoimmunity reviews.
[166] C. J. van der Woude,et al. Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety , 2015, Gut.
[167] K. Keven,et al. Pregnancy After Kidney Transplantation: Outcomes, Tacrolimus Doses, and Trough Levels. , 2015, Transplantation proceedings.
[168] J. Kwak‐Kim,et al. Immunosuppression with Tacrolimus Improved Reproductive Outcome of Women with Repeated Implantation Failure and Elevated Peripheral Blood Th1/Th2 Cell Ratios , 2015, American journal of reproductive immunology.
[169] M. Weisman,et al. Monoclonal Antibodies, Systemic Lupus Erythematosus, and Pregnancy: Insights from an Open-label Study , 2015, The Journal of Rheumatology.
[170] H. Korkes,et al. [219-POS]: Tacrolimus as the first choice of immunosuppressive therapy in kidney transplantation pregnant did not reduce significantly maternal and perinatal risks. A preliminary analysis , 2015 .
[171] P. Deepak,et al. Maternal and foetal adverse events with tumour necrosis factor‐alpha inhibitors in inflammatory bowel disease , 2014, Alimentary pharmacology & therapeutics.
[172] S. Ito,et al. Methotrexate Use in a Breastfeeding Patient with Rheumatoid Arthritis , 2014, The Journal of Rheumatology.
[173] A. Deodhar,et al. Use of belimumab throughout pregnancy to treat active systemic lupus erythematosus: a case report. , 2014, Seminars in arthritis and rheumatism.
[174] C. Pui,et al. Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study. , 2014, The Lancet. Oncology.
[175] E. D’Amico,et al. Pregnancy outcomes in multiple sclerosis patients previously treated with cyclophosphamide , 2014, Acta Neurologica Scandinavica.
[176] A. Amiot,et al. Factors associated with pregnancy outcome in anti‐TNF treated women with inflammatory bowel disease , 2014, Alimentary pharmacology & therapeutics.
[177] M. Govoni,et al. FRI0090 Pregnancy Outcome of Mothers with Rheumatic Diseases Exposed to Biological Agent during Pregnancy: A Single-Centre Study , 2014 .
[178] M. Petri,et al. OP0041 Pregnancy Outcomes for Systemic Lupus Erythematosus (SLE) Subjects with Conception during Belimumab Intravenous (IV) and Subcutaneous (SC) Placebo-Controlled Clinical Trials and Long Term Extension Trials , 2014 .
[179] R. Nissinen,et al. THU0153 Pregnancy Outcomes in Women Exposed to the Tumor Necrosis Factor Inhibitor, Golimumab , 2014 .
[180] Christopher F. Martin,et al. 1 Achievement of Developmental Milestones Among Offspring of Women With Inflammatory Bowel Disease: The PIANO Registry , 2014 .
[181] G. Koren,et al. Pregnancy Outcome After Methotrexate Treatment for Rheumatic Disease Prior to or During Early Pregnancy: A Prospective Multicenter Cohort Study , 2014, Arthritis & rheumatology.
[182] G. Shaw,et al. Corticosteroid use and risk of orofacial clefts , 2014, Birth defects research. Part A, Clinical and molecular teratology.
[183] I. Bruce,et al. O58. Longterm Outcomes of Children Born to Mothers with SLE Exposed to Hydroxychloroquine in Pregnancy , 2014 .
[184] M. Hoeltzenbein,et al. No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study. , 2014, Rheumatology.
[185] M. Clowse,et al. Systemic lupus erythematosus and pregnancy outcomes: an update and review of the literature , 2014, Current opinion in rheumatology.
[186] M. Lukáš,et al. Impact of Anti–Tumor Necrosis Factor Alpha Antibodies Administered to Pregnant Women With Inflammatory Bowel Disease on Long-term Outcome of Exposed Children , 2014, Inflammatory bowel diseases.
[187] V. Berghella,et al. Tocolytics for preterm premature rupture of membranes. , 2014, The Cochrane database of systematic reviews.
[188] W. Ray,et al. Brief Report: Risk of Adverse Fetal Outcomes Associated With Immunosuppressive Medications for Chronic Immune‐Mediated Diseases in Pregnancy , 2014, Arthritis & rheumatology.
[189] A. Ornoy,et al. Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: a prospective, comparative, observational study. , 2014, Reproductive toxicology.
[190] T. Card,et al. Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications. , 2014, Gastroenterology.
[191] M. Hebert,et al. Tacrolimus placental transfer at delivery and neonatal exposure through breast milk. , 2013, British journal of clinical pharmacology.
[192] L. Dewulf. Medicines in Pregnancy—Women and Children First? Time for a Coalition to Address a Substantial Patient Need , 2013, Therapeutic innovation & regulatory science.
[193] A. Ornoy,et al. Pregnancy outcome following in utero exposure to hydroxychloroquine: a prospective comparative observational study. , 2013, Reproductive toxicology.
[194] J. Kwon,et al. Rupture of an Unscarred Uterus in a Woman With Long-Term Steroid Treatment for Systemic Lupus Erythematosus , 2013, Obstetrics and gynecology.
[195] H. Forssberg,et al. Cognitive outcome in adolescents and young adults after repeat courses of antenatal corticosteroids. , 2013, The Journal of pediatrics.
[196] M. Lukáš,et al. Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-α therapy during pregnancy: three-center study , 2013, Scandinavian journal of gastroenterology.
[197] M. McGrath,et al. Fetal outcomes after rituximab exposure in women with autoimmune vasculitis , 2013, Annals of the rheumatic diseases.
[198] C. Kneepkens,et al. Long‐term follow‐up of children exposed intrauterine to maternal thiopurine therapy during pregnancy in females with inflammatory bowel disease , 2013, Alimentary pharmacology & therapeutics.
[199] S. Constantinescu,et al. Outcomes of Pregnancies Fathered by Solid-Organ Transplant Recipients Exposed to Mycophenolic Acid Products , 2013, Progress in transplantation.
[200] R. Fischer-Betz,et al. Low risk of renal flares and negative outcomes in women with lupus nephritis conceiving after switching from mycophenolate mofetil to azathioprine. , 2013, Rheumatology.
[201] F. Ingegnoli,et al. Pre-conceptional exposure to rituximab: comment on the article by Ojeda-Uribe et al. , 2013, Clinical Rheumatology.
[202] C. Nelson-Piercy,et al. Breastfeeding and tacrolimus: serial monitoring in breast-fed and bottle-fed infants. , 2013, Clinical journal of the American Society of Nephrology : CJASN.
[203] T. Bjørge,et al. Effects of preconceptional paternal drug exposure on birth outcomes: cohort study of 340 000 pregnancies using Norwegian population-based databases. , 2013, British journal of clinical pharmacology.
[204] M. Dubinsky,et al. Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[205] E. Kuipers,et al. Effects of discontinuing anti-tumor necrosis factor therapy during pregnancy on the course of inflammatory bowel disease and neonatal exposure. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[206] J. Mate,et al. Safety of Thiopurines and Anti-TNF-α Drugs During Pregnancy in Patients With Inflammatory Bowel Disease , 2013, The American Journal of Gastroenterology.
[207] D. Hommes,et al. Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease , 2013, Gut.
[208] P. Voulgari,et al. Fertility in male patients with seronegative spondyloarthropathies treated with infliximab. , 2013, Joint, bone, spine : revue du rhumatisme.
[209] M. Takei,et al. Successful childbearing in two women with rheumatoid arthritis and a history of miscarriage after etanercept treatment , 2013, Rheumatology International.
[210] J. Sibilia,et al. Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases , 2013, Clinical Rheumatology.
[211] S. Alkindi,et al. Successful treatment of severe thrombocytopenia with romiplostim in a pregnant patient with systemic lupus erythematosus , 2012, Lupus.
[212] T. Yuen,et al. An Update on Prenatal Diagnosis and Treatment of Congenital Adrenal Hyperplasia , 2012, Seminars in Reproductive Medicine.
[213] C. Weber-Schoendorfer,et al. Infliximab and adalimumab use during breastfeeding. , 2012, Journal of clinical gastroenterology.
[214] W. Sandborn,et al. Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry , 2012, The American Journal of Gastroenterology.
[215] Mimi Y. Kim,et al. Maternal Use of Hydroxychloroquine Is Associated With a Reduced Risk of Recurrent Anti-SSA/Ro-Antibody–Associated Cardiac Manifestations of Neonatal Lupus , 2012, Circulation.
[216] Mimi Y. Kim,et al. Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. , 2012, Arthritis and rheumatism.
[217] M. New,et al. Cognitive outcome of offspring from dexamethasone-treated pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 2012, European journal of endocrinology.
[218] R. Xu,et al. Pregnancy outcome in women exposed to leflunomide before or during pregnancy. , 2012, Arthritis and rheumatism.
[219] F. Ünal,et al. Parenthood in pediatric liver transplant patients , 2012, Pediatric Transplantation.
[220] Jiunn-ren Wu,et al. Effects of antenatal corticosteroids on neonatal outcomes in very-low-birth-weight preterm newborns: a 10-year retrospective study in a medical center. , 2012, Pediatrics and neonatology.
[221] Jing Liu,et al. Antenatal dexamethasone has no adverse effects on child physical and cognitive development: a long-term cohort follow-up investigation , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[222] A. Engeland,et al. Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150 000 pregnant women and expectant fathers , 2012, Scandinavian journal of rheumatology.
[223] E. DeFranco,et al. Antenatal Steroids for Treatment of Fetal Lung Immaturity After 34 Weeks of Gestation: An Evaluation of Neonatal Outcomes , 2012, Obstetrics and gynecology.
[224] A. Gafni,et al. Effect of Antenatal Corticosteroids on Fetal Growth and Gestational Age at Birth , 2012, Obstetrics and gynecology.
[225] F. Guerrero‐Romero,et al. Klippel-Feil syndrome in a boy exposed inadvertently to cyclophosphamide during pregnancy: a case report. , 2012, Birth defects research. Clinical and molecular teratology.
[226] M. García-Sánchez,et al. Is safety infliximb during pregnancy in patients with inflammatory bowel disease? , 2012, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.
[227] S. Alkindi,et al. Balla lupus erythematosus Successful treatment of severe thrombocytopenia with romiplostim in a pregnant patient with systemic , 2012 .
[228] R. Eliakim,et al. Detection of infliximab in breast milk of nursing mothers with inflammatory bowel disease. , 2011, Journal of Crohn's & colitis.
[229] R. Fischer-Betz,et al. Successful outcome of two pregnancies in patients with adult-onset Still's disease treated with IL-1 receptor antagonist (anakinra). , 2011, Clinical and experimental rheumatology.
[230] John M. Simpson,et al. Isolated Atrioventricular Block in the Fetus: A Retrospective, Multinational, Multicenter Study of 175 Patients , 2011, Circulation.
[231] Ning Zhang,et al. Coexisting ankylosing spondylitis and rheumatoid arthritis: a case report with literature review. , 2011, Chinese medical journal.
[232] K. Van Steen,et al. Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy , 2011, Inflammatory bowel diseases.
[233] D. Friedman,et al. Association of the idiotype:antiidiotype antibody ratio with the efficacy of intravenous immunoglobulin treatment for the prevention of recurrent autoimmune-associated congenital heart block. , 2011, Arthritis and rheumatism.
[234] T. El-toukhy,et al. Birth Defect Rates in Women Using Adalimumab (Humira®) to Treat Immunologic‐Based Infertility in IVF Patients , 2011, American journal of reproductive immunology.
[235] M. Battin,et al. Growth in the neonatal period after repeat courses of antenatal corticosteroids: data from the ACTORDS randomised trial , 2011, Archives of Disease in Childhood: Fetal and Neonatal Edition.
[236] G. Saade,et al. The Frequency of Prior Antenatal Corticosteroid Therapy in Late Preterm Birth Pregnancies , 2011, American journal of perinatology.
[237] M. Khamashta,et al. First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss. , 2011, Blood.
[238] G. Eslick,et al. The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD). , 2011, Journal of Crohn's & colitis.
[239] M. Kostaki,et al. Pregnancy during adalimumab use for psoriasis , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.
[240] S. Hernández-Díaz,et al. Patterns of medication use during pregnancy in rheumatoid arthritis , 2011, Arthritis care & research.
[241] E. Kuipers,et al. High intra‐uterine exposure to infliximab following maternal anti‐TNF treatment during pregnancy , 2011, Alimentary pharmacology & therapeutics.
[242] M. Amorim,et al. Effectiveness of antenatal corticosteroids in reducing respiratory disorders in late preterm infants: randomised clinical trial , 2011, BMJ : British Medical Journal.
[243] A. Hviid,et al. Corticosteroid use during pregnancy and risk of orofacial clefts , 2011, Canadian Medical Association Journal.
[244] D. Beghin,et al. Paternal Exposure to Methotrexate and Pregnancy Outcomes , 2011, The Journal of Rheumatology.
[245] V. Kimonis,et al. An additional patient with mycophenolate mofetil embryopathy: Cardiac and facial analyses , 2011, American journal of medical genetics. Part A.
[246] J. Bijlsma,et al. Safety of rituximab therapy during twins' pregnancy. , 2011, Rheumatology.
[247] D. Symmons,et al. Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register , 2011, Annals of the rheumatic diseases.
[248] F. M. Ribeiro,et al. Successful pregnancy after cyclophosphamide therapy for lupus nephritis , 2011, Archives of Gynecology and Obstetrics.
[249] W. DeCampli,et al. Congenital Cardiac Defects: A Possible Association of Aminopterin Syndrome and In Utero Methotrexate Exposure? , 2011, Pediatric Cardiology.
[250] N. Silverman,et al. Use of intravenous gamma globulin and corticosteroids in the treatment of maternal autoantibody-mediated cardiomyopathy. , 2011, Journal of the American College of Cardiology.
[251] E. Chakravarty,et al. Pregnancy outcomes after maternal exposure to rituximab. , 2011, Blood.
[252] A. Alsuwaida. Successful management of systemic lupus erythematosus nephritis flare-up during pregnancy with tacrolimus , 2011, Modern rheumatology.
[253] G. Lapadula,et al. Intentional etanercept use during pregnancy for maintenance of remission in rheumatoid arthritis. , 2011, Clinical and experimental rheumatology.
[254] G. Koren,et al. Cyclosporine and lactation: when the mother is willing to breastfeed. , 2011, Therapeutic drug monitoring.
[255] M. Gerosa,et al. Congenital fetal heart block: a potential therapeutic role for intravenous immunoglobulin. , 2011, Obstetrics and gynecology.
[256] D. Goulis,et al. Comparison of single versus multiple courses of antenatal betamethasone in patients with threatened preterm labor. , 2011, Clinical and experimental obstetrics & gynecology.
[257] P. Middleton,et al. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. , 2011, The Cochrane database of systematic reviews.
[258] O. Hjalmarson,et al. Effect of Antenatal Corticosteroid Treatment on Lung Function in Full-Term Newborn Infants , 2010, Neonatology.
[259] B. Cuneo,et al. A management strategy for fetal immune-mediated atrioventricular block , 2010, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[260] C. Nielsen,et al. Etanercept concentrations in maternal serum, umbilical cord serum, breast milk and child serum during breastfeeding. , 2010, Rheumatology.
[261] F. Stanley,et al. Linking a pharmaceutical claims database with a birth defects registry to investigate birth defect rates of suspected teratogens , 2010, Pharmacoepidemiology and drug safety.
[262] S. Shariq,et al. Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease. , 2010, Journal of Crohn's & colitis.
[263] A. Brucato,et al. Medical treatment of pericarditis during pregnancy. , 2010, International journal of cardiology.
[264] S. Brand,et al. Safety of adalimumab in Crohn's disease during pregnancy: case report and review of the literature. , 2010, Inflammatory bowel diseases.
[265] T. Dowswell,et al. Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy. , 2010, The Cochrane database of systematic reviews.
[266] J. Gisbert,et al. Outcomes of Pregnancies Fathered by Inflammatory Bowel Disease Patients Exposed to Thiopurines , 2010, The American Journal of Gastroenterology.
[267] G. Cetin,et al. Maternal exposure to leflunomide and methotrexate in a patient with adult-onset Still's disease. , 2010, Rheumatology.
[268] T. Ozolins. Cyclophosphamide and the Teratology Society: an awkward marriage. , 2010, Birth defects research. Part B, Developmental and reproductive toxicology.
[269] A. Rea-Rosas,et al. Holoprosencephaly and genitourinary anomalies in fetal methotrexate syndrome , 2010, American journal of medical genetics. Part A.
[270] Y. Sadovsky,et al. Administration of steroids after 34 weeks of gestation enhances fetal lung maturity profiles. , 2010, American journal of obstetrics and gynecology.
[271] G. Wolbink,et al. Correction: Predictors of damage and survival in patients with Wegener's granulomatosis: Analysis of 50 patients. , 2010, The Journal of Rheumatology.
[272] M. Clementi,et al. Bisphosphonates in patients with autoimmune rheumatic diseases: Can they be used in women of childbearing age? , 2010, Autoimmunity reviews.
[273] T. Hibi,et al. Conception outcomes and opinions about pregnancy for men with inflammatory bowel disease. , 2010, Journal of Crohn's & colitis.
[274] Mimi Y. Kim,et al. Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine , 2010, Annals of the rheumatic diseases.
[275] R. Flipo,et al. Pregnancy during TNFalpha antagonist therapy: beware the rifampin-oral contraceptive interaction. Report of two cases. , 2010, Joint, bone, spine : revue du rhumatisme.
[276] R. Xu,et al. Birth outcomes in women who have taken leflunomide during pregnancy. , 2010, Arthritis and rheumatism.
[277] A Tincani,et al. Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study. , 2010, Arthritis and rheumatism.
[278] Mimi Y Kim,et al. Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial. , 2010, Arthritis and rheumatism.
[279] A. Acar,et al. The Effect of Antenatal Steroids on Fetal Lung Maturation between the 34th and 36th Week of Pregnancy , 2010, Gynecologic and Obstetric Investigation.
[280] M. Miller. Agency , 2010 .
[281] I. Ingster-moati,et al. Visual neurophysiological dysfunction in infants exposed to hydroxychloroquine in utero , 2009, Acta paediatrica.
[282] G. Koren,et al. A pilot study of paternal drug exposure: the Motherisk experience , 2009, Reproductive toxicology.
[283] M. Khamashta,et al. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review , 2008, Annals of the rheumatic diseases.
[284] H. Harigae,et al. Pregnancy-associated thrombotic thrombocytopenic purpura with anti-centromere antibody-positive Raynaud's syndrome. , 2010, Internal medicine.
[285] R. Gold,et al. Parenthood and immunomodulation in patients with multiple sclerosis , 2010, Journal of Neurology.
[286] Yi-rong Yang,et al. The influence of immunosuppressants on the fertility of males who undergo renal transplantation and on the immune function of their offspring. , 2009, Transplant immunology.
[287] K. Shojania,et al. Coarctation of the Aorta in an Infant Exposed to Etanercept in Utero , 2009, The Journal of Rheumatology.
[288] M. Aronson,et al. Improving pregnancy counseling for women with rheumatoid arthritis taking methotrexate. , 2009, The American journal of medicine.
[289] H. Gürcan,et al. Pemphigus Vulgaris in Pregnancy: Analysis of Current Data on the Management and Outcomes , 2009, Obstetrical & gynecological survey.
[290] H. Saito,et al. Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant’s serum , 2009, Annals of the rheumatic diseases.
[291] C. Berger,et al. A patient’s wish: anakinra in pregnancy , 2009, Annals of the rheumatic diseases.
[292] A. Marti-Carvajal,et al. Medical treatments for idiopathic thrombocytopenic purpura during pregnancy. , 2009, The Cochrane database of systematic reviews.
[293] S. Somalanka,et al. Oesophageal anomaly in a newborn after maternal exposure to mycofenolate mofetil , 2009, BMJ Case Reports.
[294] C. Wagner,et al. Absence of Infliximab in Infants and Breast Milk From Nursing Mothers Receiving Therapy for Crohn's Disease Before and After Delivery , 2009, Journal of clinical gastroenterology.
[295] J. Ioannidis,et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration , 2009, BMJ : British Medical Journal.
[296] M. De Vos,et al. Cyclosporine treatment of steroid‐refractory ulcerative colitis during pregnancy , 2009, Inflammatory bowel diseases.
[297] B. Stahl,et al. Tetrada of the possible mycophenolate mofetil embryopathy: a review. , 2009, Reproductive toxicology.
[298] C. J. van der Woude,et al. Azathioprine treatment during lactation , 2009, Alimentary pharmacology & therapeutics.
[299] R. Speich,et al. Successful pregnancy in pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report , 2009, Journal of medical case reports.
[300] H. Zayed,et al. Congenital diaphragmatic hernia and microtia in a newborn with mycophenolate mofetil (MMF) exposure: Phenocopy for Fryns syndrome or broad spectrum of teratogenic effects? , 2009, American journal of medical genetics. Part A.
[301] F. Wojnarowska,et al. Pemphigoid gestationis: early onset and blister formation are associated with adverse pregnancy outcomes , 2009, The British journal of dermatology.
[302] A. Mitchell,et al. Reviewing the evidence for mycophenolate mofetil as a new teratogen: Case report and review of the literature , 2009, American journal of medical genetics. Part A.
[303] A. Brucato,et al. The impact of treatment of the fetus by maternal therapy on the fetal and postnatal outcomes for fetuses diagnosed with isolated complete atrioventricular block , 2009, Cardiology in the Young.
[304] C. Hom,et al. Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases , 2009, Pediatric rheumatology online journal.
[305] R. D'Incà,et al. Patient with severe Crohn's disease became a father while on methotrexate and infliximab therapy. , 2009, Inflammatory bowel diseases.
[306] X. Mariette,et al. Abatacept therapy and safety management. , 2009, Joint, bone, spine : revue du rhumatisme.
[307] D. Mevorach,et al. Early Diagnosis and Treatment of Atrioventricular Block in the Fetus Exposed to Maternal Anti-SSA/Ro-SSB/La Antibodies: A Prospective, Observational, Fetal Kinetocardiogram–Based Study , 2009, Circulation.
[308] F. Carrilho,et al. Follow-up of Pregnant Women With Autoimmune Hepatitis: The Disease Behavior Along With Maternal and Fetal Outcomes , 2009, Journal of clinical gastroenterology.
[309] E. Makrakis,et al. Low‐molecular‐weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome , 2009, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[310] J. Carter,et al. A Safety Assessment of Tumor Necrosis Factor Antagonists During Pregnancy: A Review of the Food and Drug Administration Database , 2009, The Journal of Rheumatology.
[311] H. Genant,et al. Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors , 2009, Annals of the rheumatic diseases.
[312] A. Allen,et al. Timing of Indicated Delivery After Antenatal Steroids in Preterm Pregnancies with Severe Hypertension , 2009, Hypertension in pregnancy.
[313] P. Voulgari,et al. Fertility and Reproduction in Male Patients with Ankylosing Spondylitis Treated with Infliximab , 2008, The Journal of Rheumatology.
[314] M. Matucci-Cerinic,et al. Pregnancy outcome in systemic lupus erythematosus complicated by anti-phospholipid antibodies. , 2008, Rheumatology.
[315] X. Mariette,et al. Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature. , 2009, Joint, bone, spine : revue du rhumatisme.
[316] B. Batko,et al. Pregnancy course and neonatal outcome after exposure to leflunomide--2 cases report and review of literature. , 2009, Przeglad lekarski.
[317] N. Danısman,et al. The effects of betamethasone treatment on clinical and laboratory features of pregnant women with HELLP syndrome , 2009, Archives of Gynecology and Obstetrics.
[318] C. Poets,et al. A pair of twins born after maternal exposure to leflunomide , 2008, Journal of Perinatology.
[319] Xiao-feng Zhu,et al. Marital status and fertility of 185 male renal transplant recipients in China. , 2008, Journal of andrology.
[320] J. Fareed,et al. Pregnancy outcome in women with antiphospholipid antibodies: report on a retrospective study. , 2008, Seminars in thrombosis and hemostasis.
[321] A. Rezvani,et al. Infertility improved by etanercept in ankylosing spondylitis , 2008, Indian journal of pharmacology.
[322] T. Hirvikoski,et al. Long-term follow-up of prenatally treated children at risk for congenital adrenal hyperplasia: does dexamethasone cause behavioural problems? , 2008, European journal of endocrinology.
[323] R. Perricone,et al. Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion. , 2008, Rheumatology.
[324] P. Cheng,et al. Sonographic diagnosis of fetal malformations associated with mycophenolate mofetil exposure in utero. , 2008, American journal of obstetrics and gynecology.
[325] G. S. Ang,et al. Mycophenolate mofetil embryopathy may be dose and timing dependent , 2008, American journal of medical genetics. Part A.
[326] J. F. Baumgratz,et al. Even low dose of mycophenolate mofetil in a mother recipient of heart transplant can seriously damage the fetus. , 2008, Transplantation.
[327] C. Gordon,et al. Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs. , 2008, Rheumatology.
[328] B. Sng,et al. Regional anaesthesia for Caesarean section in an ankylosing spondylitic patient with twin pregnancy. , 2008, European journal of anaesthesiology.
[329] B. Leiby,et al. Effect of Antenatal Corticosteroids on Survival for Neonates Born at 23 Weeks of Gestation , 2008, Obstetrics and gynecology.
[330] J. L. Pinto e Silva,et al. Postpartum dexamethasone for women with hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: a double-blind, placebo-controlled, randomized clinical trial. , 2008, American journal of obstetrics and gynecology.
[331] H. Rehder,et al. Severe Facial Clefts in Acrofacial Dysostosis: A Consequence of Prenatal Exposure to Mycophenolate Mofetil? , 2008, Obstetrics and gynecology.
[332] Mimi Y. Kim,et al. Utility of Cardiac Monitoring in Fetuses at Risk for Congenital Heart Block: The PR Interval and Dexamethasone Evaluation (PRIDE) Prospective Study , 2008, Circulation.
[333] P. Hartmann,et al. Effect of Preterm Birth and Antenatal Corticosteroid Treatment on Lactogenesis II in Women , 2008, Pediatrics.
[334] J. Davison,et al. Pregnancy after transplantation. , 2000, Transplantation reviews.
[335] A. Ledo,et al. In utero exposure to mycophenolate mofetil: A characteristic phenotype? , 2008, American journal of medical genetics. Part A.
[336] M. Velinov,et al. The fetal mycophenolate mofetil syndrome. , 2008, Clinical dysmorphology.
[337] A. Ghafari,et al. Pregnancy after renal transplantation: ten-year single-center experience. , 2008, Transplantation proceedings.
[338] P. Middleton,et al. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. , 2008, The Cochrane database of systematic reviews.
[339] M. Fawzy,et al. Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study , 2008, Archives of Gynecology and Obstetrics.
[340] Eric J. Knudtson,et al. Anomalies in a Fetus Exposed to Methotrexate in the First Trimester , 2007 .
[341] D. El‐Haieg,et al. Plasmapheresis and pregnancy outcome in patients with antiphospholipid syndrome , 2007, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[342] G. Koren,et al. Pregnancy outcome of women exposed to azathioprine during pregnancy. , 2007, Birth defects research. Part A, Clinical and molecular teratology.
[343] A. Gilman‐Sachs,et al. Elevated Th1/Th2 Cell Ratios in a Pregnant Woman with a History of RSA, Secondary Sjögren’s Syndrome and Rheumatoid Arthritis Complicated with One Fetal Demise of Twin Pregnancy , 2007, American journal of reproductive immunology.
[344] A. Tincani,et al. Immune System Development in Infants Born to Mothers with Autoimmune Disease, Exposed In Utero to Immunosuppressive Agents , 2007, American journal of perinatology.
[345] S. Takeda,et al. Effect of steroid administration and plasmapheresis to prevent fetal congenital heart block in patients with systemic lupus erythematosus and/or Sjögren's syndrome , 2007, Acta obstetricia et gynecologica Scandinavica.
[346] C. Neville,et al. Maternal exposure to leflunomide associated with blindness and cerebral palsy. , 2007, Rheumatology.
[347] R. Snanoudj,et al. Fetal malformations associated with mycophenolate mofetil for lupus nephritis. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[348] Marcus John Beasley,et al. Immune function in children born to mothers with autoimmune diseases and exposed in utero to immunosuppressants , 2007, Lupus.
[349] J. Cabane,et al. Successful pregnancy with the use of nitric oxide donors and heparin after recurrent severe preeclampsia in a woman with scleroderma. , 2007, American journal of obstetrics and gynecology.
[350] J. Triantafillidis,et al. Pregnancy and inflammatory bowel disease in Greece: A prospective study of seven cases in a single hospital setting , 2007 .
[351] C. Nelson-Piercy,et al. Azathioprine and breastfeeding—is it safe? , 2007, BJOG : an international journal of obstetrics and gynaecology.
[352] A. Tincani,et al. Response to tetanus vaccination in infants exposed in utero to immunosuppressants for maternal autoimmune disorders , 2007, Lupus.
[353] B. Kaplan,et al. Therapeutic monitoring of mycophenolate mofetil. , 2006, Clinical journal of the American Society of Nephrology : CJASN.
[354] C. Roux,et al. Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy. , 2007, Rheumatology.
[355] K. Eguchi,et al. Successful treatment of a patient with primary Sjögren's syndrome complicated with pericarditis during pregnancy. , 2007, Internal medicine.
[356] B. Afşar,et al. Mixed connective tissue disease: a case with scleroderma renal crisis following abortion , 2007, Clinical Rheumatology.
[357] Serban Constantinescu,et al. Pregnancy Outcomes in Solid Organ Transplant Recipients With Exposure to Mycophenolate Mofetil or Sirolimus , 2006, Transplantation.
[358] G. Koren,et al. Breast-Feeding During Maternal Use of Azathioprine , 2006, The Annals of pharmacotherapy.
[359] L. Magder,et al. Hydroxychloroquine in lupus pregnancy. , 2006, Arthritis and rheumatism.
[360] R. Gearry,et al. Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs. , 2006, British journal of clinical pharmacology.
[361] C. Gordon,et al. Anti-inflammatory and immunosuppressive drugs and reproduction , 2006, Arthritis research & therapy.
[362] A. Lusky,et al. Plurality-dependent risk of severe intraventricular hemorrhage among very low birth weight infants and antepartum corticosteroid treatment. , 2006, American journal of obstetrics and gynecology.
[363] J. Kavanagh,et al. Corticosteroids for cervical ripening and induction of labour. , 2006, The Cochrane database of systematic reviews.
[364] S. Giannubilo,et al. Effect of betametasone administration on platelet count in thrombocytopenic and normal pregnant women , 2006, Archives of Gynecology and Obstetrics.
[365] A. Tincani,et al. Normal neuropsychological development in children with congenital complete heart block who may or may not be exposed to high-dose dexamethasone in utero , 2006, Annals of the rheumatic diseases.
[366] P. Tsang,et al. Intravenous immunoglobulin in antiphospholipid syndrome and maternal floor infarction when standard treatment fails: a case report. , 2006, American journal of perinatology.
[367] D. Tweardy,et al. Maternal corticosteroids to prevent intrauterine exposure to hyperthermia and inflammation: a randomized, double-blind, placebo-controlled trial. , 2005, American journal of obstetrics and gynecology.
[368] S. Sezer,et al. Acute renal failure due to mesangial proliferative glomerulonephritis in a pregnant woman with primary Sjögren’s syndrome , 2006, Clinical Rheumatology.
[369] P. Lorenz,et al. Identification and management of fetuses at risk for, or affected by, congenital heart block associated with autoantibodies to SSA (Ro), SSB (La), or an HsEg5-like autoantigen , 2006, Rheumatology International.
[370] A. Franx,et al. The transplacental passage of prednisolone in pregnancies complicated by early-onset HELLP syndrome. , 2005, Placenta.
[371] A. Cavaliere,et al. Paternal and maternal exposure to leflunomide: pregnancy and neonatal outcome , 2005, Annals of the rheumatic diseases.
[372] A. Ljubić,et al. Comparison of two therapeutic protocols in patients with antiphospholipid antibodies and recurrent miscarriages. , 2005, Vojnosanitetski pregled.
[373] P. Meroni,et al. In vivo effects of maternal immunosuppression during pregnancy on the immune function of newborn infants. , 2005, Arhiv za higijenu rada i toksikologiju.
[374] J. Craig,et al. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. , 2005, The Cochrane database of systematic reviews.
[375] M. Hurtt,et al. Postnatal development of the gastrointestinal system: a species comparison. , 2005, Birth defects research. Part B, Developmental and reproductive toxicology.
[376] A. Tincani,et al. Follow-Up of Infants Exposed to Hydroxychloroquine Given to Mothers during Pregnancy and Lactation , 2005, Journal of Perinatology.
[377] J. Wan,et al. Hypertensive disease in pregnancies complicated by systemic lupus erythematosus. , 2004, American journal of obstetrics and gynecology.
[378] E. Tarım,et al. Sjögren's syndrome diagnosed in pregnancy: a case report. , 2005, The Journal of reproductive medicine.
[379] G. Lichtenstein,et al. Outcome of Pregnancy in Women Receiving Infliximab for the Treatment of Crohn's Disease and Rheumatoid Arthritis , 2004, The American Journal of Gastroenterology.
[380] W. Byrd,et al. Transfer of Inflammatory Cytokines Across the Placenta , 2004, Obstetrics and gynecology.
[381] A. Tincani,et al. Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy. , 2003, Toxicology letters.
[382] E. Trinka,et al. Linear scleroderma “en coup de sabre” coexisting with plaque-morphea: neuroradiological manifestation and response to corticosteroids , 2003, Journal of neurology, neurosurgery, and psychiatry.
[383] D. Green,et al. Pregnancy outcome of partners of male survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[384] D. Riley,et al. Kidney transplantation during the first trimester of pregnancy: immunosuppression with mycophenolate mofetil, tacrolimus, and prednisone. , 2001, Transplantation.
[385] A. Drosos,et al. Outcome of lupus pregnancy: a controlled study. , 2000, Rheumatology.
[386] B. Sibai,et al. Expectant management of severe preeclampsia remote from term. , 1999, Clinical obstetrics and gynecology.
[387] Roger M. Williams,et al. King's College Hospital Experience , 1998 .